British Thyroid Association Survey of Graves' Disease Management in the UK
The survey confirms a growing application of TRAbs, both for diagnostic and prognostic purposes. ATDs remain the preferred first-line therapy for Graves' disease, which is consistent with global trends but contrary to National Institute of Health and Care Excellence (NICE) guidance. Further studies are required to explore the clinical and pragmatic determinants of current treatment approaches.
Authors
- Koteshwara Muralidhara (ORCID: https://orcid.org/0000-0002-0041-7813)
- Onyebuchi Okosieme (ORCID: https://orcid.org/0000-0003-2221-992X)
- Bijay Vaidya (ORCID: https://orcid.org/0000-0002-2223-0494)
- Medha Agrawal
- Michael Atkinson (ORCID: https://orcid.org/0000-0002-3608-2701)
- Prakash Abraham (ORCID: https://orcid.org/0000-0003-1195-8188)
Institutions
- Swansea Bay University Health Board (GB)
- University of Exeter (GB)
- Aberdeen Royal Infirmary (GB)
- Aneurin Bevan University Health Board (GB)
- Cwm Taf University Health Board (GB)
- Kingston Hospital (GB)
- Exeter Hospital (GB)
- Cardiff University (GB)
Publication Details
- Journal
- Clinical Endocrinology
- Published
- 2025-05-08
- DOI
- https://doi.org/10.1111/cen.15266
- Citations
- 2
- Primary Topic
- Thyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.59